These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16434816)

  • 1. Four cases of Kawasaki syndrome complicated with myocarditis.
    Yoshikawa H; Nomura Y; Masuda K; Hazeki D; Yotsumoto K; Arata M; Kamenosono A; Yanagi S; Yoshinaga M; Kawano Y
    Circ J; 2006 Feb; 70(2):202-5. PubMed ID: 16434816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early combined treatment with steroid and immunoglobulin is effective for serious Kawasaki disease complicated by myocarditis and encephalopathy.
    Suga K; Inoue M; Ono A; Terada T; Kawahito M; Mori K
    J Med Invest; 2016; 63(1-2):140-3. PubMed ID: 27040070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of myocardial function using the Tei index in patients with Kawasaki disease.
    Ajami G; Borzouee M; Amoozgar H; Ashnaee F; Kashef S; Nesar MS; Nesar MS
    Cardiol Young; 2010 Feb; 20(1):44-8. PubMed ID: 20018134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome.
    Saulsbury FT
    Clin Pediatr (Phila); 2002 Oct; 41(8):597-601. PubMed ID: 12403377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA
    Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of longitudinal and radial left ventricular functions on 2-D and 3-D echocardiography before and after intravenous immunoglobulin in acute Kawasaki disease.
    Hashimoto I; Saitou Y; Sakata N; Shibata K
    Pediatr Int; 2017 Dec; 59(12):1229-1235. PubMed ID: 28892213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome.
    Rigante D; Andreozzi L; Fastiggi M; Bracci B; Natale MF; Esposito S
    Int J Mol Sci; 2016 Feb; 17(3):278. PubMed ID: 26927060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review.
    Meridor K; Shoenfeld Y; Tayer-Shifman O; Levy Y
    Medicine (Baltimore); 2021 May; 100(18):e25591. PubMed ID: 33950936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial evaluation of myocardial function using the myocardial performance index in Kawasaki disease.
    Song ES; Yoon S; Cho JH; Yang EM; Cho HJ; Choi YY; Ma JS; Eom GH; Cho YK
    World J Pediatr; 2018 Jun; 14(3):259-268. PubMed ID: 29532436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intravenous immunoglobulin compared with standard therapy is associated with improved clinical outcomes in children with acute encephalitis syndrome complicated by myocarditis.
    Bhatt GC; Sankar J; Kushwaha KP
    Pediatr Cardiol; 2012 Dec; 33(8):1370-6. PubMed ID: 22588459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocarditis and Kawasaki disease.
    Dionne A; Dahdah N
    Int J Rheum Dis; 2018 Jan; 21(1):45-49. PubMed ID: 29105303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease.
    Phadke D; Patel SS; Dominguez SR; Heizer H; Anderson MS; Glode MP; Jone PN
    Pediatr Cardiol; 2015 Dec; 36(8):1618-23. PubMed ID: 25991572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
    Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
    Downie ML; Manlhiot C; Collins TH; Chahal N; Yeung RSM; McCrindle BW
    Int J Cardiol; 2017 Jun; 236():157-161. PubMed ID: 28089146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease　- A Multicenter Retrospective Study.
    Okuma Y; Suda K; Nakaoka H; Katsube Y; Mitani Y; Yoshikane Y; Ichida F; Matsushita T; Shichino H; Shiraishi I; Abe J; Hiroe M; Yoshida T; Imanaka-Yoshida K
    Circ J; 2016 Oct; 80(11):2376-2381. PubMed ID: 27746411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.
    Doi M; Takeda T; Sakurai Y; Kato J; Hayashi T; Fukuda K; Takase T; Shima M
    J Investig Allergol Clin Immunol; 2010; 20(5):413-8. PubMed ID: 20945608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.